Predictors of spontaneous transient seizure remission in patients of medically refractory epilepsy due to mesial temporal sclerosis (MTS)

被引:1
作者
Dhiman, Vikas [1 ,2 ]
Sinha, Sanjib [2 ]
Arimappamagan, Arivazhagan [3 ]
Mahadevan, Anita [4 ]
Bharath, Rose Dawn [5 ]
Saini, Jitender [5 ]
Rajeswaran, Jamuna [6 ]
Rao, Malta Bhaskar [3 ]
Shankar, Susrala K. [4 ]
Satishchandra, Parathasarthy [2 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Clin Neurosci, Bangalore 560029, Karnataka, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India
[3] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India
[4] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India
[5] Natl Inst Mental Hlth & Neurosci, Neuroimaging & Intervent Radiol, Bangalore 560029, Karnataka, India
[6] Natl Inst Mental Hlth & Neurosci, Dept Neuropsychol, Bangalore 560029, Karnataka, India
关键词
Drug resistant epilepsy; Mesial temporal sclerosis; Seizure remission; TLE; HIPPOCAMPAL SCLEROSIS; LOBE EPILEPSY; PROGNOSTIC-FACTOR; ILAE COMMISSION; TASK-FORCE; TRIAL;
D O I
10.1016/j.eplepsyres.2014.11.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To analyze the predictors of spontaneous transient seizure remission for >= 1 year in patients with drug-resistant epilepsy (DRE) due to mesial temporal sclerosis (MTS). Methods: This analysis included 38 patients with DRE (M:F =20:18, age: 31.7 +/- 10.9 years) diagnosed with unilateral MTS (right:left = 16:22). Group I ('remission' group) comprised of patients with seizure remission (M:F =10:8, age: 32.8 +/- 12.3 years, mean seizure free period: 2.2 +/- 1.1 years; median: 2.1 years). Group II ('non-remission' group) comprised of age and gender matched 20 patients (M:F = 10:10, age: 30.7 +/- 9.7 years) with unilateral MTS who never had seizure remission and subsequently underwent epilepsy surgery. Groups I and II were compared to find the predictors associated with transient seizure remission. Results: The age at onset of seizures in group I was 13.2 +/- 11.8 years and in group II was 12.0 +/- 7.6 years. The duration of seizure was: group I - 19.7 +/- 12.5 years and group II - 19.3 +/- 7.7 years. Past history of seizure remissions (p < 0.001), frequent periods of remissions (p <0.001), first remission within a year of onset of seizures (p= 0.04) and normal EEG (p = 0.04) were the important clinical predictors associated with seizure remission in this cohort. Fifteen patients in group I (83.3%) experienced remission following either change in AED (p <= 0.001) or increase in AED dosages (p <0.001). There was no difference between the two groups regarding the type of semiology (partial vs. secondarily generalized) (p = 0.50), family history of seizures (p = 1.0), side of the lesion (p = 0.34), history of febrile seizures (p = 1.0) and the number of AEDs used (p = 0.53). Conclusion: The present study unfolds, some of the clinically relevant predictors associated with transient seizure remission in patients with DRE and MTS. Future molecular and network studies are required to understand its mechanism. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 25 条
  • [11] A FOLLOW-UP-STUDY OF INTRACTABLE SEIZURES IN CHILDHOOD
    HUTTENLOCHER, PR
    HAPKE, RJ
    [J]. ANNALS OF NEUROLOGY, 1990, 28 (05) : 699 - 705
  • [12] HIPPOCAMPAL SCLEROSIS CAN BE RELIABLY DETECTED BY MAGNETIC-RESONANCE-IMAGING
    JACKSON, GD
    BERKOVIC, SF
    TRESS, BM
    KALNINS, RM
    FABINYI, GCA
    BLADIN, PF
    [J]. NEUROLOGY, 1990, 40 (12) : 1869 - 1875
  • [13] A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy
    Kanner, A. M.
    Byrne, R.
    Chicharro, A.
    Wuu, J.
    Frey, M.
    [J]. NEUROLOGY, 2009, 72 (09) : 793 - 799
  • [14] The prognosis for control of seizures with medications in patients with MRI evidence for mesial temporal sclerosis
    Kim, WJ
    Park, SC
    Lee, SJ
    Lee, JH
    Kim, JY
    Lee, BI
    Kim, DI
    [J]. EPILEPSIA, 1999, 40 (03) : 290 - 293
  • [15] Early identification of refractory epilepsy.
    Kwan, P
    Brodie, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (05) : 314 - 319
  • [16] Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
    Kwan, Patrick
    Arzimanoglou, Alexis
    Berg, Anne T.
    Brodie, Martin J.
    Hauser, W. Allen
    Mathern, Gary
    Moshe, Solomon L.
    Perucca, Emilio
    Wiebe, Samuel
    French, Jacqueline
    [J]. EPILEPSIA, 2010, 51 (06) : 1069 - 1077
  • [17] FOCAL NEURONAL MIGRATION DISORDERS AND INTRACTABLE PARTIAL EPILEPSY - A STUDY OF 30 PATIENTS
    PALMINI, A
    ANDERMANN, F
    OLIVIER, A
    TAMPIERI, D
    ROBITAILLE, Y
    ANDERMANN, E
    WRIGHT, G
    [J]. ANNALS OF NEUROLOGY, 1991, 30 (06) : 741 - 749
  • [18] Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients
    Petrovski, S.
    Szoeke, C. E. I.
    Jones, N. C.
    Salzberg, M. R.
    Sheffield, L. J.
    Huggins, R. M.
    O'Brien, T. J.
    [J]. NEUROLOGY, 2010, 75 (11) : 1015 - 1021
  • [19] Prognostic factors in patients with mesial temporal lobe epilepsy
    Pittau, Francesca
    Bisulli, Francesca
    Mai, Roberto
    Fares, Jean Elia
    Vignatelli, Luca
    Labate, Angelo
    Naldi, Ilaria
    Avoni, Patrizia
    Parmeggiani, Antonia
    Santucci, Margherita
    Capannelli, Diana
    Di Vito, Lidia
    Gambardella, Antonio
    Baruzzi, Agostino
    Tinuper, Paolo
    [J]. EPILEPSIA, 2009, 50 : 41 - 44
  • [20] Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy
    Selwa, LM
    Schmidt, SL
    Malow, TA
    Beydoun, A
    [J]. EPILEPSIA, 2003, 44 (12) : 1568 - 1572